ROVI Spain: Madrid


    Last Updated: Sep 9, 2022 5:38 p.m. CEDT Delayed quote


    -0.16 -0.34%
    Previous Close
    Advanced Charting
    Volume: 104K 65 Day Avg: 115.38K
    90% vs Avg
    46.30 Day Range 47.48
    45.10 52 Week Range 74.90

    Your Watchlists

    Customize 江湖电竞最新版比赛(江湖电竞投注app网站)

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ROVI Overview

    Key Data

    • Open €46.30
    • Day Range 46.30 - 47.48
    • 52 Week Range 45.10 - 74.90
    • Market Cap €2.5B
    • Shares Outstanding 54.02M
    • Public Float 20.85M
    • Beta N/A
    • Rev. per Employee €422.06K
    • P/E Ratio 14.00
    • EPS €3.34
    • Yield 1.66%
    • Dividend €0.77
    • Ex-Dividend Date Jul 5, 2022
    • Short Interest N/A
    • % of Float Shorted N/A
    • Average Volume 115.38K


    5 Day
    • -4.73%
    1 Month
    • -8.97%
    3 Month
    • -17.93%
    • -36.72%
    1 Year
    • -18.92%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 10 Full Ratings

    Recent News

    Read full story

    Moderna in bid to double COVID-19 vaccine production to up to 3 billion doses in 2022

    Read full story

    Coronavirus update: Global cases of COVID-19 top 12 million, and WHO warns pandemic is ‘not under control’

    Moderna signs on for another COVID-19 vaccine manufacturing deal

    Shares of Moderna Inc. gained 0.5% in premarket trading on Thursday after the drugmaker announced another manufacturing deal for its still investigational COVID-19 vaccine. As part of the deal, Laboratorios Farmacéuticos ...

    CVS Caremark, Deer Consumer, ETrade, Hasbro, Novavax

    A roundup of stocks seeing significant moves in U.S. markets on Monday.

    Novavax, Rovi end flu-vaccine-development plan

    TEL AVIV (江湖电竞最新版比赛(江湖电竞投注app网站)) -- Novavax Inc., the Rockville, Md., biotech company focused on infectious diseases, said it ended talks aimed at a collaboration with Rovi Pharmaceuticals, the Madrid drugmaker, to develop Novavax...

    No Headlines Available

    Laboratorios Farmaceuticos Rovi S.A.

    Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.


    Name Chg % Market Cap
    Recordati S.p.A. -0.88% €8.46B
    Biotechnology Assets S.A. 11.11% €5.82M
    Lavipharm S.A. 6.86% €8.68M
    Almirall S.A. 2.98% €1.62B